Decisions, Decisions . . . SRF Coactivators and Smooth Muscle Myogenesis
Mark W. Majesky S mooth muscle-restricted gene transcription depends on a highly conserved cis-regulatory element termed a CArG box [CC(A/T) 6 GG]. The CArG box binds serum response factor (SRF), an evolutionarily conserved MADS (MDM1, agamous, deficiens, SRF) domain-containing protein that is required for specification of smooth, cardiac, and skeletal muscle lineages from early mesoderm. 1 SRF is a multifunctional protein that not only binds DNA but also provides docking surfaces within the conserved core MADS domain for interaction with a wide variety of accessory cofactors. Most, but not all, smooth muscle cell (SMC) marker genes examined to date require SRF interactions with pairs of CArG-like elements that often contain single G/C substitutions in the AT-rich core region. However, SRFCArG interactions alone are not sufficient to produce the diversity of smooth muscle subtypes found within the vascular system. A report by Yoshida et al in this issue of Circulation Research confirms and extends previous work by Wang et al, 2, 3 Chen et al, 4 and Du et al, 5 suggesting that myocardin is a potent SRF-dependent coactivator for smooth muscle differentiation. 6 
Control of SRF-Dependent Transcription by Accessory Cofactors
SRF-CArG box interactions confer context-dependent and signal-responsive control of muscle-specific gene transcription ( Figure) . This is accomplished at multiple levels of regulation including control of SRF expression, cytoplasmic to nuclear translocation, alternative splicing, and posttranslational modifications of SRF itself. Perhaps the most important mechanism for control of CArG box-dependent transcription is the physical association of SRF with various cell-restricted and/or signal-dependent accessory factors that confer coactivator or corepressor activity via ternary complex formation. 
Myocardin and MRTFs Are Novel SRF Coactivators
Myocardin is a SAP (SAF-A/B, acinus, PIAS) domaincontaining protein that was discovered by Olson and colleagues during an in silico screen for genes that are selectively expressed in early cardiac development. 2 Myocardin contains conserved basic, polyglutamine-rich (Q-rich), and SAP domains in the N-terminal portion of the protein and a strong transcriptional transactivation domain at the C-terminus. Wang et al 2 first showed that expression of myocardin is restricted to cardiac and smooth muscle lineages in developing mouse embryos, and that it is capable of potent transactivation of CArG box-containing promoter-reporter constructs in a manner that is strictly dependent on its association with SRF. Chen et al 4 showed that myocardin expression is maintained in adult aortic media and is downregulated in all cultured SMC lines examined. In fact, these authors reported that some SMC cultures expressed robust levels of SM-calponin but undetectable levels of myocardin. Likewise, Du et al 5 showed that embryonic day 9.5 (E9.5) mouse aorta strongly expresses SM22␣ and SM ␣-actin with little or no detectable myocardin expression. The observations that CArG-dependent smooth muscle marker genes are expressed in cells and tissues in which myocardin mRNA is undetectable may be explained by the presence of one or more myocardin-related transcription factors (MRTFs). MRTF-A and MRTF-B were discovered by Wang et al 3 on screening cDNA libraries with myocardin-related probes obtained from EST database searches with the mouse myocardin cDNA sequence. MRTF-A and MRTF-B share strong sequence homology with myocardin in the basic and Q-rich domains, which are the SRF-binding portions of the molecule. MRTF-A activated CArG-dependent SMC promoters to levels similar to that produced by myocardin, whereas MRTF-B was less effective. MRTF-A is ubiquitously expressed throughout the mouse embryo at E10.5, and at lower levels by E13.5, whereas MRTF-B is expressed in a variety of epithelial cells, enteric smooth muscle, and mesenchymal cells of the lung and olfactory tissues. 3 Of course, it is also possible that initial activation of SMC marker genes in vascular development depends on one or more SRF accessory cofactors other than myocardin or MRTFs (see below). In this case, myocardin may function in the maintenance or ampli-fication of SMC differentiation as development of the vessel wall proceeds. Regardless of the role that myocardin or MRTFs play in the initial steps of SMC differentiation from committed progenitors, downregulation of myocardin expression with a dominant-negative myocardin mutant protein or small-interfering RNA (siRNA) greatly reduced ongoing SM22␣, SM ␣-actin, and SM-MHC promoter activity in adult aortic SMCs. 5, 6 Myocardin Activates Smooth Muscle Genes in Non-SMCs
Forced expression of myocardin in non-SMCs activated SMC marker gene expression in mouse embryonic stem (ES) cells 3, 5 and in L6 myoblasts. 4 The ability of myocardin to activate SMC reporter genes was abolished in SRF Ϫ/Ϫ ES cells and was restored upon introduction of SRF expression vectors into SRF Ϫ/Ϫ ES cells. 3, 5 Of particular interest is the present report by Yoshida et al. 6 These authors previously developed a cell line, called A404, which represents an SMC progenitor that is present in small numbers in P19 mouse embryonal carcinoma cell lines. 9 Isolation of this SMC progenitor subset was accomplished by introduction of an SM ␣-actin promoter/intron-driven puromycin resistance gene followed by treatment with retinoic acid (RA) plus puromycin. Of the surviving clones, one in particular exhibited rapid and extensive differentiation to SMCs upon stimulation with RA and was designated A404. While parental P19 cells do not express myocardin, undifferentiated A404 cells express low levels of myocardin, which are markedly increased along with SMC markers after stimulation with RA. 6 In this system, SRF expression levels are high in undifferentiated cells and do not increase over the time course of SMC differentiation. Chromatin immunoprecipitation (ChIP) assays showed that CArG elements of SMC target genes are not accessible in undifferentiated cells. However, stimulation with RA led to an increase in SRF binding to SM ␣-actin and SM-MHC CArG elements within intact chromatin in differentiated cells. 9 Although the effects of inhibiting myocardin expression in A404 cells were not tested, studies using dominantnegative myocardin or siRNA specific for myocardin in cultures of adult rat aortic SMCs showed that endogenous SM ␣-actin and SM-MHC gene expression was myocardindependent. 6 Moreover, myocardin was found in an SRFcontaining complex that forms on a 95-bp probe containing CArG-A and CArG-B elements from the SM ␣-actin proximal promoter when nuclear extracts from SMCs, but not endothelial cells, were used to perform electrophoretic mobility shift assays. 6 
SRF Interacts With Multiple Transcriptional Coactivators and Corepressors
The evolutionarily conserved MADS domain serves as a platform for binding of a diverse group of accessory proteins that control CArG-dependent transcription. In addition to myocardin and MRTFs, the SRF-MADS box can also physically interact with NK class homeodomain proteins including Nkx2.5, Nkx3.1, and Nkx3.2. Carson et al 10 reported that a conserved NKE site proximal to an adjacent CArG element in the SM ␥-actin promoter binds Nkx3.1 and promotes physical association with SRF via homeodomain-MADS box interactions. The combination of Nkx3.1 and SRF strongly coactivated SM ␥-actin promoter activity in CV1 cells. Nishida et al 11 reported that the homeodomain of Nkx3.2 and the zinc-finger basic domain of GATA6 can physically interact with the SRF-MADS box. A multiprotein complex composed of SRF, Nkx3.2, and GATA6 is correlated with strong transactivation of the chick ␣1-integrin promoter activity in 10T1/2 cells. 11 In addition to NK homeodomains, the paired class homeodomain protein Phox1, its mouse orthologue Mhox, as well as Barx2B coassociate with SRF and increase the affinity of SRF for binding to DNA. 15, 16 SRF homeodomain interactions can also inhibit transcription. The homeodomain-only protein (HOP) physically interacts with the SRF-MADS domain leading to strong inhibition of CArG-dependent transcription. 12 Factors that promote the interaction of SRF with critical accessory proteins are also being identified. Of particular interest in this regard is the recent identification of double LIM domain-containing cysteine-rich proteins Crp1 and Crp2 as highly efficient bridging proteins that promote assembly of SRF-GATA factor complexes and greatly potentiate CArG-dependent transcription of SMC marker genes. 13 Introduction of Crp1 or Crp2, together with SRF and GATA6, induced the expression of multiple SM marker genes in 10T1/2 mesenchymal cells. 13 
Summary
Accessory cofactors for SRF play key roles in signalresponsive control of CArG-dependent transcription. 14 Myocardin is expressed in developing and adult vascular SMCs, physically associates with SRF, and greatly potentiates SRFdependent transcription of multiple SMC marker genes. [2] [3] [4] [5] [6] While it is tempting to speculate that myocardin will turn out to be a key factor in control of vascular SMC differentiation in vivo, it is unlikely to account for the full range of SMC differentiation phenotypes described in normal and diseased artery wall. In that regard, other SRF cofactors including 
